Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Study showed AstraZeneca’s exenatide once-weekly suspension for autoinjection provided superior HbA1c reductions vs. twice-daily exenatide (Byetta®) in adults with type 2 diabetes
-
FDA approves MOVANTIK™ (naloxegol) tablets C-II for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain
-
AstraZeneca and Lilly announce alliance to develop and commercialise BACE inhibitor AZD3293 for Alzheimer’s disease
-
AstraZeneca to present research from its innovative diabetes portfolio at the 2014 Meeting of the European Association for the Study of Diabetes
-
Benralizumab Phase II COPD study published in The Lancet Respiratory Medicine
-
AstraZeneca and Redx Pharma agree research collaboration targeting genetic drivers of tumour growth
-
New data indicates Brilinta/Brilique™ has the flexibility to be initiated pre-hospital or in hospital in STEMI patients
-
AstraZeneca announces partnership with Illumina to develop next generation gene sequencing panel for companion diagnostic tests
-
AstraZeneca and Mitsubishi Tanabe Pharma Corporation announce research collaboration in diabetic nephropathy
-
AstraZeneca announces positive top-line results from the Phase III programme of CAZ-AVI in patients with complicated intra-abdominal infections (cIAI)
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
